A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ...

Iron deficiency—when there's too little iron in the blood—may affect a quarter of the world's population, and in particular, women of reproductive age. Symptoms can include fatigue and shortness of ...

Pediatric patients with high-risk neuroblastoma had significantly lower 5-year survival rates in induction and/or ...

Q1 2025 Earnings Call Transcript May 7, 2025 Geron Corporation beats earnings expectations. Reported EPS is $-0.03, ...

John Levine, M.D., a graft-versus-host-disease expert at the Icahn School of Medicine at Mount Sinai in New York, makes a ...

The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...

The pressure on physicians to see more patients per hour varies by specialty and practice setting. Let's start with which ...

Fintel reports that on May 8, 2025, Chardan Capital initiated coverage of Centessa Pharmaceuticals plc - Depositary Receipt ( ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

Amandeep Salhotra, MD, discusses Orca-T and its evaluation in the phase 3 Precision-T trial in patients with advanced ...

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...